Southern Co. (SO) Exceeds Market Returns: Some Facts to Consider
ZACKS· 2025-07-22 23:01
Southern Co. (SO) ended the recent trading session at $95.85, demonstrating a +1.12% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.06% for the day. On the other hand, the Dow registered a gain of 0.41%, and the technology-centric Nasdaq decreased by 0.39%. In terms of valuation, Southern Co. is currently trading at a Forward P/E ratio of 22.17. This indicates a premium in contrast to its industry's Forward P/E of 18.52. Investors should also note ...
United Parcel Service (UPS) Surpasses Market Returns: Some Facts Worth Knowing
ZACKS· 2025-07-22 23:01
Market participants will be closely following the financial results of United Parcel Service in its upcoming release. The company plans to announce its earnings on July 29, 2025. In that report, analysts expect United Parcel Service to post earnings of $1.56 per share. This would mark a year-over-year decline of 12.85%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $20.85 billion, down 4.43% from the year-ago period. Investors should also take note of any recent adjustments ...
Tyson Foods (TSN) Surpasses Market Returns: Some Facts Worth Knowing
ZACKS· 2025-07-22 23:01
Tyson Foods (TSN) closed at $54.47 in the latest trading session, marking a +2.18% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.06%. Meanwhile, the Dow experienced a rise of 0.41%, and the technology-dominated Nasdaq saw a decrease of 0.39%. The meat producer's shares have seen a decrease of 3.27% over the last month, not keeping up with the Consumer Staples sector's loss of 0% and the S&P 500's gain of 5.88%. The investment community will be closely monito ...
Langer Heinrich Mine FY2026 Guidance
GlobeNewswire News Room· 2025-07-22 22:53
Core Viewpoint - Paladin Energy Ltd has provided guidance for FY2026 regarding the Langer Heinrich Mine (LHM), highlighting operational ramp-up, production expectations, and uranium price sensitivities based on its sales contract portfolio [1][2]. Production Guidance - The LHM is expected to produce between 4.0 million pounds (Mlb) and 4.4 Mlb of U3O8 in FY2026, with sales projected between 3.8 Mlb and 4.2 Mlb [3]. - The cost of production is estimated to be between $44 and $48 per pound [3]. - Capital and exploration expenditure is forecasted to be between $26 million and $32 million [3]. Mining Operations - The LHM commenced FY2026 with approximately 2.2 million tonnes (Mt) of stockpiled medium-grade ore and 49% of its planned mining fleet capacity operational [4]. - The remaining mining fleet is expected to be delivered in late 2025 and operational in the second half of FY2026 [4]. - Mining activities will focus on the G-pit area, with minor activities in the F and J pits towards the end of the financial year [4]. Ore Processing - Production volumes are anticipated to vary throughout FY2026, primarily due to limited access to primary mined ore in the first half [6]. - A higher level of primary ore feed is expected in the second half, leading to increased production [6]. - Improvements in processing plant performance from FY2025 are expected to be maintained in FY2026 [7]. Sales and Pricing - Paladin plans to continue uranium deliveries to customers in the US, Europe, and Asia, while seeking new contracts with high-quality counterparties [8]. - Sales volumes and pricing are expected to fluctuate quarterly based on shipment timing and contract terms [8]. - Forecasted realised uranium prices for FY2026 under various spot price assumptions are as follows: - At a $40 spot price, the realised price is expected to be $54 per pound - At a $60 spot price, the realised price is expected to be $62 per pound - At a $80 spot price, the realised price is expected to be $71 per pound - At a $100 spot price, the realised price is expected to be $79 per pound - At a $120 spot price, the realised price is expected to be $87 per pound - At a $140 spot price, the realised price is expected to be $94 per pound [10].
New Gold (NGD) Laps the Stock Market: Here's Why
ZACKS· 2025-07-22 22:51
Company Performance - New Gold's stock increased by 1.11% to $4.54, outperforming the S&P 500's daily gain of 0.06% [1] - Over the past month, New Gold's shares have depreciated by 8.93%, underperforming the Basic Materials sector's gain of 4.69% and the S&P 500's gain of 5.88% [1] Earnings Expectations - New Gold is scheduled to release its earnings report on July 28, 2025, with analysts expecting earnings of $0.1 per share, indicating a year-over-year growth of 400% [2] - For the full year, Zacks Consensus Estimates project earnings of $0.47 per share and revenue of $1.31 billion, reflecting changes of +135% and +41.81% from the previous year [2] Analyst Estimates - Recent changes to analyst estimates for New Gold are important as they reflect evolving short-term business trends, with positive revisions indicating analysts' confidence in the company's performance and profit potential [3] Zacks Rank System - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), has a history of outperforming, with 1 stocks returning an average annual gain of +25% since 1988 [5] - New Gold currently holds a Zacks Rank of 1 (Strong Buy), with the consensus EPS projection moving 11.24% higher in the past 30 days [5] Valuation Metrics - New Gold is currently traded at a Forward P/E ratio of 9.55, which is a discount compared to the industry average Forward P/E of 11.86 [6] - The Mining - Gold industry, part of the Basic Materials sector, has a Zacks Industry Rank of 11, placing it in the top 5% of over 250 industries [6] Industry Performance - The strength of individual industry groups is measured by the Zacks Industry Rank, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]
DXP Enterprises (DXPE) Outperforms Broader Market: What You Need to Know
ZACKS· 2025-07-22 22:51
Group 1 - DXP Enterprises (DXPE) closed at $99.71, marking a +1.38% move from the prior day, outperforming the S&P 500 which gained 0.06% [1] - Over the past month, shares of DXP Enterprises have appreciated by 17.36%, significantly exceeding the Industrial Products sector's gain of 6.94% and the S&P 500's gain of 5.88% [1] - The Zacks Consensus Estimates forecast earnings of $5.3 per share and revenue of $0 million for the entire year, indicating changes of +17.52% and 0%, respectively, compared to the previous year [2] Group 2 - Recent adjustments to analyst estimates for DXP Enterprises indicate a positive outlook, with positive revisions seen as a sign of optimism about the business [3] - The Zacks Rank system, which incorporates estimate changes, currently rates DXP Enterprises as 2 (Buy), reflecting a strong potential for stock performance [5] - DXP Enterprises has a Forward P/E ratio of 18.56, which is a discount compared to the industry average Forward P/E of 22.2, indicating potential value [6] Group 3 - The Manufacturing - General Industrial industry, part of the Industrial Products sector, has a Zacks Industry Rank of 32, placing it in the top 13% of over 250 industries [6] - The strength of individual industry groups is measured by the Zacks Industry Rank, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]
ALTO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Alto Neuroscience, Inc. (ANRO) and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-07-22 22:49
Core Viewpoint - A class action lawsuit has been filed against Alto Neuroscience, Inc. for allegedly misleading investors regarding the effectiveness of its drug ALTO-100 during the class period from February 2, 2024, to October 22, 2024 [2][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of all individuals and entities who purchased Alto securities during the specified class period [2]. - Investors have until September 19, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [2]. - The complaint alleges that the Offering Documents for the IPO were negligently prepared and that key information about ALTO-100's effectiveness was not disclosed [3]. Group 2: Impact on Stock Price - On October 22, 2024, Alto announced that ALTO-100 did not meet its primary endpoint in a Phase 2b trial for treating Major Depressive Disorder (MDD), leading to a significant stock price drop [4]. - Following the announcement, Alto's stock price fell by $10.17 per share, or 69.99%, closing at $4.36 per share on October 23, 2024 [4]. Group 3: Contact Information - Investors who suffered losses or have questions regarding the lawsuit can contact Bragar Eagel & Squire, P.C. for more information [5][8].
EQT Corporation (EQT) Tops Q2 Earnings Estimates
ZACKS· 2025-07-22 22:46
Group 1: Earnings Performance - EQT Corporation reported quarterly earnings of $0.45 per share, exceeding the Zacks Consensus Estimate of $0.44 per share, compared to a loss of $0.08 per share a year ago, representing an earnings surprise of +2.27% [1] - Over the last four quarters, the company has surpassed consensus EPS estimates four times [2] - The company posted revenues of $1.6 billion for the quarter ended June 2025, missing the Zacks Consensus Estimate by 10.81%, compared to year-ago revenues of $1.18 billion [2] Group 2: Stock Performance and Outlook - EQT shares have increased approximately 16.1% since the beginning of the year, outperforming the S&P 500's gain of 7.2% [3] - The current consensus EPS estimate for the coming quarter is $0.66 on revenues of $1.98 billion, and for the current fiscal year, it is $3.37 on revenues of $8.37 billion [7] - The estimate revisions trend for EQT was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Group 3: Industry Context - The Oil and Gas - Exploration and Production - United States industry is currently in the bottom 28% of over 250 Zacks industries, which may impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that tracking these revisions can be beneficial for investors [5]
Bristol Myers Squibb (BMY) Outperforms Broader Market: What You Need to Know
ZACKS· 2025-07-22 22:46
Bristol Myers Squibb (BMY) ended the recent trading session at $48.02, demonstrating a +2.85% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.06%. On the other hand, the Dow registered a gain of 0.41%, and the technology-centric Nasdaq decreased by 0.39%. The stock of biopharmaceutical company has fallen by 0.49% in the past month, leading the Medical sector's loss of 1.83% and undershooting the S&P 500's gain of 5.88%.The investment comm ...
First Bank (FRBA) Q2 Earnings Lag Estimates
ZACKS· 2025-07-22 22:46
Group 1 - First Bank reported quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.43 per share, and down from $0.47 per share a year ago, representing an earnings surprise of -4.65% [1] - The company posted revenues of $36.71 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 3.50%, compared to year-ago revenues of $31.23 million [2] - Over the last four quarters, First Bank has surpassed consensus revenue estimates three times [2] Group 2 - The stock has gained approximately 10.4% since the beginning of the year, outperforming the S&P 500's gain of 7.2% [3] - The current consensus EPS estimate for the coming quarter is $0.46 on revenues of $36.42 million, and for the current fiscal year, it is $1.69 on revenues of $142.94 million [7] - The Zacks Industry Rank for Banks - Northeast is currently in the top 30% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]